Question

Somatic genome editing modifies the DNA of an individual's non-reproductive cells to
treat diseases, with changes not passed to offspring, and has been used in clinical
applications. Germline genome editing involves altering the DNA of embryos, sperm,
or eggs, which would create heritable changes in future generations. While somatic
editing is more established, germline editing is still largely in the research phase due to
significant safety and ethical concerns. (click all that apply) (3 points)
O Is this an ethical issue?
O Is the unknown outcome an issue?
O Is this a financial issue?

Answer 1

Selected:
- Is this an ethical issue? — Yes.
- Is the unknown outcome an issue? — Yes.
- Is this a financial issue? — No.

Brief rationale: Germline editing raises clear ethical concerns (consent of future generations, equity, eugenics) and safety/unknown long-term outcomes are major issues (off-target effects, heritable risks). The prompt does not indicate financial concerns as a primary issue.